Enhancement of Inpatient Mortality Prognostication with Machine Learning in a Prospective Global Cohort of Patients with Cirrhosis with External Validation

Hepatology

Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study

Lancet Gastroenterol Hepatol

Patidar KR, Ma AT, Juanola A, Barone A, Incicco S, Kulkarni AV, Hernández JLP, Wentworth B, Asrani SK, Alessandria C, Abdelkader NA, Wong YJ, Xie Q, Pyrsopoulos NT, Kim SE, Fouad Y, Torre A, Cerda E, Ferrer JD, Maiwall R, Simonetto DA, Papp M, Orman ES, Perricone G, Solé C, Lange CM, Farias AQ, Pereira G, Gadano A, Caraceni P, Thevenot T, Verma N, Kim JH, Vorobioff JD, Cordova-Gallardo J, Ivashkin V, Roblero JP, Maan R, Toledo C, Gioia S, Fassio E, Marino M, Nabilou P, Vargas V, Merli M, Goncalves LL, Rabinowich L, Krag A, Balcar L, Montes P, Mattos AZ, Bruns T, Mohammed A, Laleman W, Carrera E, Cabrera MC, Girala M, Samant H, Raevens S, Madaleno J, Kim RW, Arab JP, Presa J, Ferreira CN, Galante A, Allegretti AS, Takkenberg B, Marciano S, Sarin SK, Durand F, Ginès P, Angeli P, Solà E, Piano S, International Club of Ascites GLOBAL AKI team

doi: 10.1016/S2468-1253(25)00006-8

Hepatology

Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

Lancet Gastroenterol Hepatol

Cao Z, Wong F, Choudhury AK, Kamath PS, Topazian M, Torre A, Hayes PC, George J, Idilman R, Seto WK, Desalegn H, Alvares-da-Silva MR, Bush BJ, Thacker LR, Xie Q, Bajaj JS, CLEARED Consortium

doi: 10.1016/S2468-1253(24)00224-3

Inflammatory Bowel Disease

Prevalence, incidence and mortality of inflammatory bowel disease in the Netherlands: development and external validation of machine learning models

J Crohns Colitis

van Linschoten RCA, van Leeuwen N, van Klaveren D, Pierik PMJ, Creemers R, Hendrix EMB, Hazelzet PJA, van der Woude PCJ, West RL, van Noord D

doi: 10.1093/ecco-jcc/jjaf017

Hepatology

Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study

Lancet Gastroenterol Hepatol

Lindvig KP, Thorhauge KH, Hansen JK, Kjærgaard M, Hansen CD, Johansen S, Lyngbeck E, Israelsen M, Andersen P, Bech KT, Torp N, Schnefeld HL, Detlefsen S, Möller S, Graupera I, Trelle MB, Antonsen S, Harris R, Kårhus LL, Bjørnsbo KS, Brøns C, Hansen T, Geier A, Wedemeyer H, Zeuzem S, Schattenberg JM, Ginès P, Guha IN, Krag A, Thiele M

doi: 10.1016/S2468-1253(24)00274-7

Gastrointestinal CancerHepatology

Primary liver cancer risk and mortality in patients with alcohol-related cirrhosis in England and Denmark: observational cohort studies

Am J Gastroenterol

Jensen MD, West PJ, Crooks C, Morling JR, Kraglund F, Card T, Askgaard G, Jepsen PP

doi: 10.14309/ajg.0000000000003077

Esophagus Diseases

Deep Learning Model for Histologic Diagnosis of Dysplastic Barrett's Esophagus: Multisite Cohort External Validation

Am J Gastroenterol

Codipilly DC, Faghani S, Vogelsang D, Moassefi M, Garg N, Hagen C, Lewis J, Leggett CL, Patil P, Konda V, Al Diffalha S, Peter S, Brinkerhoff B, Wong M, Otaki F, Katzka DA, Wani S, Shaheen N, Erickson BJ, Iyer PG

doi: 10.14309/ajg.0000000000003495

Further Publications

In-hospital Mortality in Patients with Lower Gastrointestinal Bleeding: Development and Validation of a Prediction Score

Endoscopy

Dajti E, Frazzoni L, Castellet-Farrús S, Guardiola J, Sinagra E, Anderloni A, Ferrara F, Gkolfakis P, Camus Duboc M, Mandarino FV, Sadeghi A, Lorenzo-Zúñiga V, Perez S, Triantafyllou K, Curado MP, Facciorusso A, Collatuzzo G, Hassan C, Radaelli F, Fuccio L

doi: 10.1055/a-2541-2312

Hepatology

Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis

J Hepatol

Fortea JI, Alvarado-Tapias E, Simbrunner B, Ezcurra I, Hernández-Gea V, Aracil C, Llop E, Puente A, Roig C, Reiberger T, García-Pagan JC, Calleja JL, Ferrero-Gregori A, Mandorfer M, Villanueva C, Crespo J

doi: 10.1016/j.jhep.2024.12.017

Hepatology

Impact of Renin-Angiotensin-Aldosterone System Inhibitors on Liver-Related Events and Mortality in Patients With Cirrhosis: A Meta-Analysis of Real-World Evidence

J Gastroenterol Hepatol

Chen Y, Zhai D, Shen J, Hu W

doi: 10.1111/jgh.70003

Related content

Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study

Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium

Prevalence, incidence and mortality of inflammatory bowel disease in the Netherlands: development and external validation of machine learning models

Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study

Primary liver cancer risk and mortality in patients with alcohol-related cirrhosis in England and Denmark: observational cohort studies

Deep Learning Model for Histologic Diagnosis of Dysplastic Barrett's Esophagus: Multisite Cohort External Validation

In-hospital Mortality in Patients with Lower Gastrointestinal Bleeding: Development and Validation of a Prediction Score

Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis

Impact of Renin-Angiotensin-Aldosterone System Inhibitors on Liver-Related Events and Mortality in Patients With Cirrhosis: A Meta-Analysis of Real-World Evidence